Volume restoration planning

Facial Fat Grafting Consultation Guide

Facial fat grafting transfers processed fat from a donor area to selected facial planes. It requires two-site planning and honest discussion of swelling, contour, variable retention and the possibility that staged treatment may be considered.

Published by Shanghai Xingyi Baiweier GroupFirst published 2026-08-23Last materially updated 2026-08-23Institutional planning informationSources and review basis

SECTION 01

Define the recipient area and visual goal

Cheek, temple, forehead, tear-trough, fold and chin concerns involve different depths and nearby structures. Ask the clinician to identify where volume loss, skeletal shape, tissue descent or surface shadow contributes before recommending transfer.

Adding volume cannot reproduce a filtered face or replace lifting in every case. Overfilling can alter identity or create heaviness, so the plan should state the intended areas and limits.

  • Mark each proposed recipient area separately.
  • Compare volume restoration with lifting or no treatment.
  • Disclose all previous filler and fat-transfer procedures.

SECTION 02

Include donor-site planning

The abdomen, thigh or another area may be discussed as a donor site, but suitability depends on available tissue, scars, prior liposuction and the harvest required. Small-volume harvest is not equivalent to a full body-contouring procedure.

Ask where incisions are expected, whether compression is advised and how bruising, contour change, numbness or wound concerns at the donor site will be monitored.

SECTION 03

Understand retention and asymmetry uncertainty

Transferred fat survival varies with tissue, technique, blood supply, health factors and healing. Some volume is expected to change, but an exact retention percentage or final symmetry cannot be promised for an individual.

Discuss cysts, nodules, calcification, infection, fat necrosis, contour irregularity and prolonged swelling. The consent discussion should also address rare but severe vascular or embolic complications, including tissue injury and blindness. Sudden vision change, severe eye pain, new weakness, speech difficulty, chest pain or breathing difficulty requires immediate local emergency care. Ask when additional treatment could be considered rather than planning it in advance.

SECTION 04

Coordinate two-site recovery

The care pathway depends on the final procedure and assessment. If the treating team selects general anesthesia and the patient is clinically cleared, the group's common planning pathway is about two inpatient days of observation. A local-anesthesia case may leave the same day after observation and discharge clearance. If external sutures are used, review or removal is often considered around day 7, but the treating team sets the actual schedule. International patients should travel only after clinical clearance.

Pressure, massage and activity instructions can differ between the face and donor area. International patients need both areas reviewed and must wait for clinical travel clearance. The finance team can provide a tailored written quote once every treated and donor area is defined.

  • Ask for separate face and donor-site instructions.
  • Plan clothing and luggage around movement restrictions.
  • Do not judge retained volume during early swelling.

CARE PATHWAY

The care pathway depends on the final procedure

  • 01Anesthesia, observation and inpatient needs cannot be decided from the procedure name alone. They depend on the final technique, medical history and treating team’s assessment.
  • 02Within the group’s typical planning, general-anesthesia surgery may include about two inpatient days, while some local-anesthesia procedures may permit same-day departure after observation and clinical clearance.
  • 03When removable external sutures are used, review or removal is often planned around day 7, but the doctor and individual healing determine the actual date.
These timings describe a typical planning pathway, not a promise or personal discharge instruction. The treating doctor’s assessment, the exact procedure, anesthesia, test results and recovery always control the final plan.

CONSULTATION CHECKLIST

What to confirm before making a decision

  1. 01List each facial concern and previous injectable treatment.
  2. 02Confirm the donor site and whether body contouring is excluded.
  3. 03Discuss variable retention and possible staged decisions.
  4. 04Review recipient and donor-site complications.
  5. 05Arrange reviews and travel only after clinical clearance.

FAQ

Questions patients often ask

These answers provide general context. A treating doctor must interpret them for an individual case.

Will all transferred facial fat survive?

No. Retention varies, and early swelling is not the final volume. The surgeon should explain uncertainty without guaranteeing a percentage.

Is facial fat grafting the same as filler?

No. They use different materials and procedures, have different risks and behave differently over time. Neither is automatically appropriate.

Does harvesting fat contour the donor area?

A small harvest should not be assumed to provide formal body contouring. Ask the surgeon to define the harvest boundary and expected donor-site change.

Can I book a second session before the first?

It is generally more useful to let the treating team assess healing and retained volume before deciding whether any further treatment is appropriate.

SOURCES & REVIEW BASIS

External references for general context

These references support general education and review context only. They do not establish an individual diagnosis, treatment plan, discharge date or travel clearance.

This guide is general institutional information, not diagnosis, personal medical advice, a treatment recommendation, a price quotation or a promise of outcome. Suitability, risks, anesthesia, recovery, costs and travel timing require an in-person assessment, a defined plan and written informed consent.
WhatsApp